Equities
  • Price (EUR)0.645
  • Today's Change0.02 / 3.20%
  • Shares traded0.00
  • 1 Year change-33.51%
  • Beta1.2923
Data delayed at least 15 minutes, as of Feb 13 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Yidu Tech Inc is an investment holding company primarily engaged in providing healthcare solutions built on big data and artificial intelligence (AI) technologies. The Company mainly operates its business through three segments. The Big Data Platform and Solutions segment is engaged in providing data intelligence platform and data analytics-driven solutions. The Life Sciences Solutions segment is engaged in supporting the full life-cycle management of pharmaceuticals and medical devices, which covers all phases from clinical development to post-market commercialization. The Health Management Platform and Solutions segment is engaged in providing AI-enabled health management solutions. The Company conducts its business in the domestic and overseas markets.

  • Revenue in HKD (TTM)842.23m
  • Net income in HKD-100.74m
  • Incorporated2014
  • Employees823.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.